Clinical trial
Brachytherapy in Treating Patients With Recurrent Malignant Glioma
NCT00045474 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00045474 |
|---|---|
| Title | Brachytherapy in Treating Patients With Recurrent Malignant Glioma |
| Official title | Phase I Brachytherapy Dose Escalating Study Using the Proxima Therapeutics, Inc. GliaSite RTS in Patients With Recurrent Malignant Gliomas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Procedure, Radiation |
| Interventions | adjuvant therapy, iodine I 125 |
| Start date | Oct 1, 2002 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 9, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: